1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable

Technology appraisal guidance [TA765] Published: 02 February 2022

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

  • Evaluation report  
  • Appraisal consultation committee papers  PDF 4.09 MB 02 February 2022  
  • Final appraisal determination committee papers PDF 968 KB 02 February 2022